Back
AbCellera Biologics Vs. InMed Pharmaceuticals Industry Stock Comparison
Buy
60
ABCL
AbCellera Biologics
Last Price:
3.83
Seasonality Move:
1.48%
Sell
22
INM
InMed Pharmaceuticals
Last Price:
0.26
Seasonality Move:
-22.11%
Buy
60
AbCellera Biologics (ABCL)
is a Buy
Is AbCellera Biologics a Buy, Sell or Hold?
- The current AbCellera Biologics [ABCL] share price is $3.83. The Score for ABCL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ABCL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
InMed Pharmaceuticals (INM)
is a Sell
Is InMed Pharmaceuticals a Buy, Sell or Hold?
- The current InMed Pharmaceuticals [INM] share price is $0.26. The Score for INM is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- INM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABCL Stock Price Chart
What is AbCellera Biologics's stock price today?
-
The AbCellera Biologics share price today is $3.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing selling pressure, which indicates risk of future bearish movement.
INM Stock Price Chart
What is InMed Pharmaceuticals's stock price today?
-
The InMed Pharmaceuticals share price today is $0.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INM is experiencing selling pressure, which indicates risk of future bearish movement.
ABCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 41.74 | Sell |
Chaikin Money Flow: | -893528 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.77 - 4.29) | Sell |
Bollinger Bands (100): | (4.23 - 5.47) | Sell |
INM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 42.83 | Sell |
Chaikin Money Flow: | -36168 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.25 - 0.33) | Sell |
Bollinger Bands (100): | (0.3 - 0.4) | Sell |
ABCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.93 | Sell |
20-day SMA: | 3.92 | Sell |
50-day SMA: | 4.35 | Sell |
200-day SMA: | 4.93 | Sell |
8-day EMA: | 3.91 | Sell |
20-day EMA: | 3.99 | Sell |
50-day EMA: | 4.29 | Sell |
200-day EMA: | 5.23 | Sell |
INM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.26 | Sell |
20-day SMA: | 0.27 | Sell |
50-day SMA: | 0.32 | Sell |
200-day SMA: | 0.51 | Sell |
8-day EMA: | 0.27 | Sell |
20-day EMA: | 0.28 | Sell |
50-day EMA: | 0.31 | Sell |
200-day EMA: | 0.91 | Sell |
AbCellera Biologics Earnings Growth & ABCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.08 per share.
InMed Pharmaceuticals Earnings Growth & INM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AbCellera Biologics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
InMed Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |